Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 697
interventional 616
Observational 76
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 210
Drug 193
Device 51
Other 44
Behavioral 27
Biological|placebo 14
Procedure 11
Biological 8
Device|placebo 8
Drug|Procedure 7
Drug|Other 5
Other|placebo 4
Device|Drug 3
Device|Other 3
Behavioral|Drug 2
Behavioral|Drug|placebo 2
Behavioral|Other 2
Biological|Drug 2
Dietary Supplement|Other 2
Dietary Supplement|placebo 2
placebo 2
Behavioral|Device 1
Behavioral|Drug|Other 1
Biological|Other 1
Combination Product 1
Combination Product|Diagnostic Test|Other 1
Combination Product|Drug 1
Device|Drug|placebo 1
Diagnostic Test 1
Dietary Supplement 1
Dietary Supplement|Drug|Other 1
Dietary Supplement|Drug|placebo 1
Drug|Other|Procedure 1
Other|Procedure 1
placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 286
NA 79
Denmark 39
Italy 16
Canada 14
Japan 14
Turkey 13
Brazil 10
China 9
France 8
Israel 8
Germany 7
Norway 6
Australia 5
Spain 5
Belgium 4
Iran, Islamic Republic of 4
Korea, Republic of 4
United Kingdom 4
Sweden 3
United States|Canada|Czechia|Finland|Israel|Japan|Poland|Russian Federation|Spain 3
Netherlands 2
Switzerland 2
Taiwan 2
United States|Belgium|Canada|Finland|Italy|Japan|Poland 2
United States|Canada 2
United States|Canada|Czechia|Denmark|Finland|Germany|Norway|Poland|Sweden|United Kingdom 2
United States|Georgia 2
United States|Israel 2
Argentina|India|Korea, Republic of|Lebanon|Malaysia|Mexico|Philippines|Singapore|Taiwan|Thailand|Vietnam 1
Australia|Austria|Belgium|Czechia|Denmark|Finland|France|Germany|Greece|Italy|Netherlands|Norway|Spain|Sweden|Switzerland|United Kingdom 1
Australia|Canada|Netherlands|United Kingdom 1
Australia|Chile|New Zealand 1
Australia|New Zealand 1
Belgium|Bulgaria|Austria|Czech Republic|Denmark|France|Germany|Greece|Hungary|Ireland|Norway|Poland|Portugal|Russian Federation|Saudi Arabia|Slovenia|Spain|Switzerland|Turkey|United Kingdom 1
Belgium|Czech Republic|Denmark|France|Germany|Greece|Hungary|Italy|Netherlands|Norway|Portugal|Spain|Sweden|Turkey| 1
Belgium|Denmark|Finland|France|Germany|Italy|Netherlands|Norway|Spain 1
Belgium|Denmark|Germany|Greece|Netherlands|Norway|Spain|United Kingdom 1
Belgium|Denmark|Spain 1
Belgium|El Salvador|France|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Belgium|Finland|France|Germany|Spain 1
Belgium|Germany 1
China|India|Russian Federation 1
China|Korea, Republic of|Malaysia|Philippines|Singapore|Taiwan|Thailand|Vietnam 1
Czechia|Poland|Slovakia 1
Denmark|Finland|Netherlands|Norway|Sweden| 1
Denmark|Hungary|South Africa|United Kingdom 1
Estonia|Finland 1
Finland|Germany 1
Finland|Germany|Netherlands 1
Finland|Sweden 1
Germany|Hungary|Poland|South Africa|United Kingdom 1
Germany|United States|Spain 1
India 1
Malaysia 1
Mexico 1
Réunion 1
Thailand 1
Turkey| 1
Ukraine|United States|Belgium|Czechia|Denmark|Georgia|Germany|Hungary|Italy|Russian Federation|Slovakia|Spain|United Kingdom 1
United States|Argentina|Canada|Czechia|Germany|Israel|Italy|Mexico|Netherlands|Puerto Rico|Spain|Taiwan|United Kingdom 1
United States|Argentina|Czechia|Germany|Israel|Korea, Republic of|Mexico|Netherlands|Puerto Rico|Spain|Taiwan|United Kingdom 1
United States|Australia|Austria|Czechia|Finland|France|Hungary|Italy|Poland|Spain|United Kingdom 1
United States|Australia|Canada|China|Czechia|Denmark|France|Germany|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|Sweden|Taiwan 1
United States|Australia|Georgia|New Zealand 1
United States|Australia|Korea, Republic of 1
United States|Austria|Belgium|Canada|Czechia|Finland|Germany|Netherlands|Poland|Slovakia|Sweden|Turkey|United Kingdom 1
United States|Austria|Belgium|China|Czechia|Denmark|France|Germany|Hungary|India|Italy|Mexico|Netherlands|Russian Federation|Spain|Switzerland|United Kingdom 1
United States|Austria|Belgium|Czechia|Finland|France|Germany|Greece|Ireland|Israel|Italy|Netherlands|Poland|Portugal|Slovakia|Spain|United Kingdom 1
United States|Austria|Canada|Czechia|Denmark|Finland|Germany|Sweden 1
United States|Belgium|Canada|Czechia|France|Germany|Hungary|Japan|Korea, Republic of|Netherlands|Puerto Rico|Spain|United Kingdom 1
United States|Belgium|Canada|Czechia|France|Germany|India|Italy|Japan|Mexico|Netherlands|Puerto Rico|Romania|Russian Federation|Spain|United Kingdom 1
United States|Belgium|Canada|France|Hungary|Puerto Rico 1
United States|Belgium|Czechia|Denmark|Finland|France|Georgia|Germany|Italy|Poland|Spain|United Kingdom 1
United States|Belgium|Czechia|Denmark|Finland|France|Germany|Italy|Netherlands|Poland|Spain|Sweden|Switzerland|United Kingdom 1
United States|Belgium|Netherlands 1
United States|Canada|Croatia|Germany|Switzerland|United Kingdom 1
United States|Canada|Denmark|Finland|Germany|Norway|Sweden 1
United States|Canada|Puerto Rico 1
United States|Canada|United Kingdom 1
United States|Czechia|Finland|Germany|Greece|Israel|Poland|Russian Federation|Spain 1
United States|Denmark|France|Greece|Portugal|Russian Federation|Spain|Switzerland 1
United States|Denmark|Germany|Puerto Rico|Spain 1
United States|Estonia|Finland|Hungary|Latvia|Poland|Serbia|Slovakia 1
United States|Germany|United Kingdom 1
United States|Japan|Puerto Rico 1
United States|Norway 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 377
2 42
3 14
4 11
5 4
6 9
7 4
8 1
9 8
10 5
11 1
12 2
13 3
14 2
15 3
16 6
17 1
19 1
20 3
21 2
22 5
23 1
24 2
25 4
26 2
27 3
28 2
29 2
30 3
31 2
32 2
33 1
34 4
35 1
36 2
37 1
38 1
39 3
40 1
41 4
42 1
43 2
44 2
45 1
47 1
49 3
50 3
52 2
53 1
56 2
57 1
59 1
62 1
63 1
65 2
66 2
68 1
69 2
70 2
72 1
74 2
75 1
76 1
77 1
79 2
82 1
83 1
87 1
90 1
92 2
93 1
95 2
98 1
102 1
107 1
109 2
112 1
113 2
114 1
116 1
117 2
129 1
138 1
139 1
141 1
145 1
148 1
163 1
177 1
196 1
273 1
275 1

Phase

Phase Study_Count
N/A 203
Phase 3 161
Phase 4 93
Phase 2 90
Phase 1 41
Phase 2/Phase 3 18
Early Phase 1 5
Phase 1/Phase 2 5

Number of Arms

Number_of_Arms Count_of_Studies
1 80
2 308
3 89
4 44
5 15
6 11
7 2
8 1
9 1
NA 65

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 6.0 2.00000 4.00000 8.0 17.0000 25.0 12.0000 8.0000
1st Qu. 13.0 30.00000 24.00000 10.0 70.0000 72.5 192.0000 56.0000
Median 16.0 51.00000 35.00000 46.0 173.0000 282.5 450.0000 120.0000
Mean 17.6 84.66502 44.07317 32.4 238.5056 829.5 628.4907 216.7742
3rd Qu. 16.0 91.00000 50.00000 48.0 366.0000 775.5 875.0000 250.0000
Max. 37.0 907.00000 163.00000 50.0 885.0000 4548.0 3005.0000 1653.0000

Trial Group Type

group_type Group_Count
Experimental 640
Placebo Comparator 271
Active Comparator 267
NA 65
Other 64
Sham Comparator 37
No Intervention 32

Intervention Model

intervention_model Study_Count
Parallel Assignment 400
Single Group Assignment 111
Crossover Assignment 92
Factorial Assignment 7
Sequential Assignment 4
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 447
Prevention 88
Basic Science 33
Other 15
NA 13
Diagnostic 9
Supportive Care 5
Educational/Counseling/Training 3
Health Services Research 3

Observational Studies

Studies by Country

Country Study_Count
United States 26
NA 20
Denmark 4
France 4
Canada 3
Korea, Republic of 3
Germany 2
Italy 2
United Kingdom 2
Belgium|Germany|Luxembourg|Spain|Sweden|United Kingdom 1
Brazil 1
Egypt 1
France|Italy|Spain 1
Germany|Italy|Norway|Russian Federation|Spain|Sweden|United Kingdom 1
Germany|Spain|Sweden|United Kingdom 1
Greece 1
Israel 1
Kazakhstan|Ukraine 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 66
2 2
3 2
4 1
10 1
15 1
18 1
30 1
77 1

Enrollment Metrics

Measure Observational
Min 1.0
1st Qu 56.5
Median 109.0
Mean 1524.6
3rd Qu 479.5
Max 61737.0

Observation Model

observational_model Study_Count
Cohort 23
Case-Only 17
Case-Control 10
Case Control 7
NA 7
Other 5
Case-Crossover 2
Ecologic or Community 2
Family-Based 2
Defined Population, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 48
Cross-Sectional 13
Retrospective 11
NA 2
Cross-Sectional, Prospective 1
Other 1

Registries

Studies by Country

Country Study_Count
China 2
Canada 1
NA 1
United States 1

Sites per Study

Site_count Study_Count
1 4
19 1

Enrollment Metrics

Measure Registries
Min 200.0
1st Qu 201.0
Median 868.0
Mean 773.8
3rd Qu 1100.0
Max 1500.0

Registry Model

observational_model Study_Count
Cohort 4
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 5

Follow-up

target_duration Study_Count
1 Year 3
12 Years 1
20 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT00071786 Family Study of Affective and Anxiety Spectrum Disorders https://ClinicalTrials.gov/show/NCT00071786 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03301441 Sensitivity to Acute Cerebral Ischemia in Migrainers https://ClinicalTrials.gov/show/NCT03301441 Recruiting University Hospital, Montpellier 2021-02-28
NCT03231241 Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics https://ClinicalTrials.gov/show/NCT03231241 Recruiting Stanford University 2020-08-15
NCT03175263 OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain https://ClinicalTrials.gov/show/NCT03175263 Completed University Hospital, Limoges 2015-12-30
NCT03125525 Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Refractory Migraine https://ClinicalTrials.gov/show/NCT03125525 Completed Corfu Headache Clinic 2016-06-30
NCT02910921 Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit https://ClinicalTrials.gov/show/NCT02910921 Completed Second Opinion Health 2018-07-31
NCT02901756 A Combination of Coenzyme Q10, Feverfew and Magnesium for Migraine Prophylaxis : a Prospective Observational Study https://ClinicalTrials.gov/show/NCT02901756 Completed Pileje 2015-12-31
NCT02616978 Retrospective Study on the Use of CEFALY® Device During Migraine Attacks https://ClinicalTrials.gov/show/NCT02616978 Completed Cefaly Technology 2015-12-31
NCT02615314 Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and Migraine https://ClinicalTrials.gov/show/NCT02615314 Completed Anadolu Medical Center 2015-06-30
NCT02564822 Effects of the Visual Stimulation on the Motor and Visual Cortex in Migraneurs With and Without Aura https://ClinicalTrials.gov/show/NCT02564822 Completed Universidade Federal de Pernambuco 2016-06-30
NCT02502123 Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® https://ClinicalTrials.gov/show/NCT02502123 Completed Allergan 2019-01-29
NCT02468622 Transcriptomic and Biochemical Changes During a Migraine Attack https://ClinicalTrials.gov/show/NCT02468622 Completed Danish Headache Center 2016-06-30
NCT02309606 Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography https://ClinicalTrials.gov/show/NCT02309606 Completed Danish Headache Center 2017-08-31
NCT02259387 Adolescents With Migraine: What’s Stress Got To Do With It? https://ClinicalTrials.gov/show/NCT02259387 Completed University of Colorado, Denver 2017-09-15
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache https://ClinicalTrials.gov/show/NCT02227758 Completed Abbott Medical Devices 2015-12-31
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients’ Satisfaction With the Treatment in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT02115269 Completed Abbott 2015-11-30
NCT02047695 Women With Migraine With Aura Neuroimaging Study https://ClinicalTrials.gov/show/NCT02047695 Completed Odense University Hospital 2015-04-30
NCT01976611 Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea https://ClinicalTrials.gov/show/NCT01976611 Completed Allergan 2015-02-28
NCT01946126 A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache https://ClinicalTrials.gov/show/NCT01946126 Completed Allergan 2014-04-30
NCT01916395 Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache https://ClinicalTrials.gov/show/NCT01916395 Completed Westside Family Medical Center, P.C. 2010-12-31
NCT01845051 Is There a Comorbidity Between Migraine and Allergic Rhinitis? https://ClinicalTrials.gov/show/NCT01845051 Completed Baskent University 2013-03-31
NCT01836874 A Study of Prophylaxis for Migraine Patients With Topiramate in India https://ClinicalTrials.gov/show/NCT01836874 Completed Janssen-Cilag Ltd. 2008-07-31
NCT01749410 A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines https://ClinicalTrials.gov/show/NCT01749410 Completed Allergan 2014-05-31
NCT01741246 Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging https://ClinicalTrials.gov/show/NCT01741246 Completed University of California, San Francisco 2015-06-30
NCT01720862 Migraine and Body Composition https://ClinicalTrials.gov/show/NCT01720862 Completed Johns Hopkins University 2015-10-31
NCT01706003 The Utility of Telemedicine in the Management of Migraine https://ClinicalTrials.gov/show/NCT01706003 Completed University of Texas Southwestern Medical Center 2018-10-31
NCT01687088 Smell Sensitivity in Chronic Migraine: A Case-Control Study https://ClinicalTrials.gov/show/NCT01687088 Completed Thomas Jefferson University 2012-03-31
NCT01686581 An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine https://ClinicalTrials.gov/show/NCT01686581 Completed Allergan 2016-10-12
NCT01648530 Chronic Migraine Epidemiology and Outcomes Study https://ClinicalTrials.gov/show/NCT01648530 Completed Allergan 2013-11-30
NCT01435941 Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine https://ClinicalTrials.gov/show/NCT01435941 Completed GlaxoSmithKline 2011-02-28
NCT01432379 BOTOX® Prophylaxis in Patients With Chronic Migraine https://ClinicalTrials.gov/show/NCT01432379 Completed Allergan 2015-05-12
NCT01388699 Migraine and Endothelial Dysfunction https://ClinicalTrials.gov/show/NCT01388699 Completed Charite University, Berlin, Germany 2011-08-31
NCT01381523 A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data https://ClinicalTrials.gov/show/NCT01381523 Completed GlaxoSmithKline 2011-06-30
NCT01381497 Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy https://ClinicalTrials.gov/show/NCT01381497 Completed GlaxoSmithKline 2011-10-31
NCT01376193 Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet https://ClinicalTrials.gov/show/NCT01376193 Completed GlaxoSmithKline 2011-10-31
NCT01376141 Drug Use Investigation for IMIGRAN Tablet https://ClinicalTrials.gov/show/NCT01376141 Completed GlaxoSmithKline 2005-02-28
NCT01332500 Treximet â„¢ Pharmacy Budget Impact Model Database Validation Study https://ClinicalTrials.gov/show/NCT01332500 Completed GlaxoSmithKline 2010-03-31
NCT01332383 Special Drug Use Investigation for AMERGE® Tablet (Long-term) https://ClinicalTrials.gov/show/NCT01332383 Completed GlaxoSmithKline 2013-10-31
NCT04413110 PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine https://ClinicalTrials.gov/show/NCT04413110 Completed Mansoura University Hospital 2020-03-01
NCT04324710 Gene Expression of Endocannabinoid System in Episodic and Chronic Migraine Patients https://ClinicalTrials.gov/show/NCT04324710 Completed IRCCS National Neurological Institute “C. Mondino” Foundation 2019-12-31
NCT04211454 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches https://ClinicalTrials.gov/show/NCT04211454 Recruiting ProgenaBiome 2023-03-31
NCT04152434 Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy https://ClinicalTrials.gov/show/NCT04152434 Completed Clinique des Céphalées de Montréal 2019-07-30
NCT04091321 Association Between Chronic Headache and Back Pain With Childbirth https://ClinicalTrials.gov/show/NCT04091321 Active, not recruiting Stanford University 2020-09-12
NCT04019496 Neurophysiology of Prophylactic Treatment in Migraine https://ClinicalTrials.gov/show/NCT04019496 Recruiting University Medicine Greifswald 2020-12-31
NCT04012593 Diary-based Study on the Course of Hormone-withdrawal Migraines https://ClinicalTrials.gov/show/NCT04012593 Recruiting University of Zurich 2019-10-31
NCT03831659 Migraine and Infertility https://ClinicalTrials.gov/show/NCT03831659 Recruiting Assistance Publique - Hôpitaux de Paris 2020-10-31
NCT03766412 High School Start Time and Teen Migraine Frequency https://ClinicalTrials.gov/show/NCT03766412 Completed University of California, San Francisco 2018-10-15
NCT03727672 Salivary Inflammatory Markers in Tension Type Headache and Migraine https://ClinicalTrials.gov/show/NCT03727672 Recruiting National and Kapodistrian University of Athens 2019-12-30
NCT03662295 Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention https://ClinicalTrials.gov/show/NCT03662295 Completed Quality Living, Inc. 2019-11-13
NCT03626805 Muscle Tenderness and Hardness in Migraine Patients https://ClinicalTrials.gov/show/NCT03626805 Completed Danish Headache Center 2018-12-18
NCT03577548 Influence of Main Psychological and Social Factors on Primary Headaches https://ClinicalTrials.gov/show/NCT03577548 Recruiting Centre Hospitalier Universitaire de Besancon 2018-08-31
NCT03536936 Oxygenation and Perfusion in Patients With Acute Migraine Attacks https://ClinicalTrials.gov/show/NCT03536936 Completed University Hospital Inselspital, Berne 2018-04-30
NCT03494673 Prediction of WMH in Migraine Using a BOLD-CVR Map https://ClinicalTrials.gov/show/NCT03494673 Active, not recruiting Samsung Medical Center 2020-02-28
NCT03490500 Using the S100B Protein for Emergency Headache Management Care https://ClinicalTrials.gov/show/NCT03490500 Completed Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 2020-01-24
NCT03487978 Longitudinal Changes of Brain Functional Connectivity in Migraine https://ClinicalTrials.gov/show/NCT03487978 Active, not recruiting Samsung Medical Center 2022-02-28
NCT01257880 Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP) https://ClinicalTrials.gov/show/NCT01257880 Completed Swedish Medical Center 2011-05-31
NCT03872050 Deep Phenotyping of Rosacea and Migraine https://ClinicalTrials.gov/show/NCT03872050 Active, not recruiting Danish Headache Center 2020-09-01
NCT01004835 The Migraine and Pain Study GeneBank at Scripps Clinic Registry (MAPS) https://ClinicalTrials.gov/show/NCT01004835 Completed Scripps Translational Science Institute 2015-05-31
NCT00930852 A Pilot Study of Migraine and Appetite Behaviour in Children https://ClinicalTrials.gov/show/NCT00930852 Completed Alder Hey Children’s NHS Foundation Trust 2010-08-31
NCT00904150 Study of the Molecular Genetics of Menstrual Migraine https://ClinicalTrials.gov/show/NCT00904150 Completed The City of London Migraine Clinic 2013-08-31
NCT00868556 fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease? https://ClinicalTrials.gov/show/NCT00868556 Completed The Cleveland Clinic 2009-08-31
NCT04361721 Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine https://ClinicalTrials.gov/show/NCT04361721 Recruiting IRCCS National Neurological Institute “C. Mondino” Foundation 2020-06-30
NCT00772473 Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine https://ClinicalTrials.gov/show/NCT00772473 Completed Clinvest 2009-01-31
NCT00754611 The Evolution and Management of Migraine Recurrence Beyond 24 Hours https://ClinicalTrials.gov/show/NCT00754611 Completed Rowan University 2010-12-31
NCT00750594 Patent Foramen Ovale in Children With Migraine Headaches https://ClinicalTrials.gov/show/NCT00750594 Completed University of Utah 2011-03-31
NCT00727974 Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines https://ClinicalTrials.gov/show/NCT00727974 Completed Medical College of Wisconsin 2013-06-12
NCT00725140 Standardized sTudy With Almotriptan in eaRly Treatment of Migraine https://ClinicalTrials.gov/show/NCT00725140 Completed Almirall, S.A. 2009-04-30
NCT00642564 Study on Migraine and Headache in Epileptic Patients https://ClinicalTrials.gov/show/NCT00642564 Completed Johnson & Johnson Taiwan Ltd 2009-03-31
NCT00600717 Clinical Applications of High-Frequency Oscillations https://ClinicalTrials.gov/show/NCT00600717 Enrolling by invitation Children’s Hospital Medical Center, Cincinnati 2020-07-01
NCT00471861 Inflammatory Markers in Patients With Active Migraine Headaches https://ClinicalTrials.gov/show/NCT00471861 Completed Westside Family Medical Center, P.C. NA
NCT00460005 Clinical Study Of Migraine Evolution https://ClinicalTrials.gov/show/NCT00460005 Completed GlaxoSmithKline NA
NCT00457184 Thrombophilia and Migraine, Are They Related? https://ClinicalTrials.gov/show/NCT00457184 Completed HaEmek Medical Center, Israel NA
NCT00335803 A Research Study To Compare Two Kinds Of Daily Headache https://ClinicalTrials.gov/show/NCT00335803 Completed Thomas Jefferson University NA
NCT00297336 An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine https://ClinicalTrials.gov/show/NCT00297336 Completed Janssen Cilag Pharmaceutica S.A.C.I., Greece NA
NCT00203346 Research Study Examining Nerve Block for Migraine https://ClinicalTrials.gov/show/NCT00203346 Completed Thomas Jefferson University NA
NCT00329771 Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack. https://ClinicalTrials.gov/show/NCT00329771 Completed Thomas Jefferson University 2006-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02425696 Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population https://ClinicalTrials.gov/show/NCT02425696 Completed First Hospital of Jilin University 2016-08-31
NCT01804517 Impact of a Nurse for Migraine Management: the IMPACT Project https://ClinicalTrials.gov/show/NCT01804517 Completed Notre-Dame Hospital, Montreal, Quebec, Canada 2015-11-30
NCT03742024 Study of Pediatric Migraine: The Pediatric Migraine Registry https://ClinicalTrials.gov/show/NCT03742024 Active, not recruiting Duke University 2021-01-31
NCT03418766 The Relationship Between Right-to-left Shunt and Brain White Matter Lesions in Patients With Migraine https://ClinicalTrials.gov/show/NCT03418766 Recruiting First Hospital of Jilin University 2019-07-01
NCT01059604 Sumatriptan and Naratriptan Pregnancy Registry https://ClinicalTrials.gov/show/NCT01059604 Completed GlaxoSmithKline 2013-04-30